院外心脏骤停幸存者焦虑或抑郁与长期死亡率分析
该纵向人群队列研究基于韩国国民健康保险服务数据库,纳入2005年1月1日至2015年12月31日因院外心脏骤停住院且存活≥1年的2373例患者,随访至多14年。1年内诊断抑郁或焦虑者397例(16.7%),其中抑郁251例(10.6%)、焦虑227例(9.6%)。抑郁或焦虑组长期死亡率35.5%(141/397)高于无抑郁或焦虑组的27.0%(534/1976)(P=0.001);校正后长期死亡HR在抑郁或焦虑合计人群为1.41(95%CI 1.17-1.70),抑郁为1.44(95%CI 1.16-1.79),焦虑为1.20(95%CI 0.94-1.53)。作者认为可能需要针对院外心脏骤停幸存者的心理与神经康复干预以改善长期生存。
要点
- 院外心脏骤停后存活≥1年的2373例患者中,1年内抑郁或焦虑合计患病率16.7%(397/2373),抑郁10.6%(251/2373),焦虑9.6%(227/2373)。
- 抑郁或焦虑组长期死亡率35.5%(141/397),无抑郁或焦虑组27.0%(534/1976),P=0.001。
- 校正后长期死亡HR:抑郁或焦虑合计1.41(95%CI 1.17-1.70);抑郁1.44(95%CI 1.16-1.79);焦虑1.20(95%CI 0.94-1.53),焦虑未达统计学显著。
- 随访至多14年,中位年龄53.0岁(IQR 44.0-62.0),男性1860例(78.4%)。
- 作者认为可能需要针对院外心脏骤停幸存者的心理与神经康复干预以改善长期生存。
适用人群与场景
- 2005年1月1日至2015年12月31日因院外心脏骤停住院、存活1年或以上的患者。
- 排除因创伤或非医学原因(如损伤、中毒、窒息、烧伤或过敏反应)导致心脏骤停的患者。
诊断标准与关键阈值
- 抑郁或焦虑诊断依据韩国国民健康保险服务数据库在心脏骤停后1年内的诊断记录。
研究设计与关键结果
- 研究类型:纵向人群队列研究;样本量2373例;人群为院外心脏骤停后存活≥1年者;中位年龄53.0岁(IQR 44.0-62.0),男性1860例(78.4%)。
- 暴露:1年内诊断抑郁或焦虑397例(16.7%),其中抑郁251例(10.6%),焦虑227例(9.6%);对照为无抑郁或焦虑1976例。
- 主要终点长期累积死亡率:抑郁或焦虑组35.5%(141/397) vs 无抑郁或焦虑组27.0%(534/1976),P=0.001。
- 多因素Cox比例风险回归校正后长期死亡HR:抑郁或焦虑合计1.41(95%CI 1.17-1.70);抑郁1.44(95%CI 1.16-1.79);焦虑1.20(95%CI 0.94-1.53)。
- 随访时间:至多14年。
证据类型、等级与局限
- 证据类型:纵向人群队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,针对院外心脏骤停幸存者的心理与神经康复干预可能有助于改善长期生存。
- 本研究提示,院外心脏骤停后1年内诊断抑郁或焦虑与长期死亡率升高相关(校正HR 1.41,95%CI 1.17-1.70)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The recent American Heart Association guidelines added a sixth link in the chain of survival highlighting recovery and emphasized the importance of psychiatric outcome and recovery for survivors of out-of-hospital cardiac arrest (OHCA). The prevalence of psychiatric disorders among this population was higher than that in the general population.
OBJECTIVE: To examine the prevalence of depression or anxiety and the association of these conditions with long-term mortality among individuals who survive OHCA.
DESIGN, SETTING, AND PARTICIPANTS: A longitudinal population-based cohort study was conducted to analyze long-term prognosis in patients hospitalized for OHCA between January 1, 2005, and December 31, 2015, who survived for 1 year or longer. Patients with cardiac arrest due to traumatic or nonmedical causes, such as injuries, poisoning, asphyxiation, burns, or anaphylaxis, were excluded. Data were extracted on depression or anxiety diagnoses in this population within 1 year from the database of the Korean National Health Insurance Service and analyzed April 7, 2022, and reanalyzed January 19 to 20, 2023.
MAIN OUTCOMES AND MEASURES: Follow-up data were obtained for up to 14 years, and the primary outcome was long-term cumulative mortality. Long-term mortality among patients with and without a diagnosis of depression or anxiety were evaluated.
RESULTS: The analysis included 2373 patients; 1860 (78.4%) were male, and the median age was 53.0 (IQR, 44.0-62.0) years . A total of 397 (16.7%) patients were diagnosed with depression or anxiety, 251 (10.6%) were diagnosed with depression, and 227 (9.6%) were diagnosed with anxiety. The incidence of long-term mortality was significantly higher in the group diagnosed with depression or anxiety than in the group without depression or anxiety (141 of 397 [35.5%] vs 534 of 1976 [27.0%]; P = .001). With multivariate Cox proportional hazards regression analysis, the adjusted hazard ratio of long-term mortality for total patients with depression or anxiety was 1.41 (95% CI, 1.17-1.70); depression, 1.44 (95% CI, 1.16-1.79); and anxiety, 1.20 (95% CI, 0.94-1.53).
CONCLUSIONS AND RELEVANCE: In this study, among the patients who experienced OHCA, those diagnosed with depression or anxiety had higher long-term mortality rates than those without depression or anxiety. These findings suggest that psychological and neurologic rehabilitation intervention for survivors of OHCA may be needed to improve long-term survival.
参考来源
- Lee J, Cho Y, Oh J, et al. Analysis of Anxiety or Depression and Long-term Mortality Among Survivors of Out-of-Hospital Cardiac Arrest. JAMA Netw Open. 2023. PMID: 37043200. doi:10.1001/jamanetworkopen.2023.7809
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。